Davis P L, Brown S R, Chen K W. "一种的合成方法" [P]. US Patent, US 9121195 B2, 2025-12-12.
Fischer A B, O'Brien P Q, Anderson J P. "Method for the Synthesis of 3',4'-Dihydro-2'H-spiro[cyclohexane-1,1'-pyrrolo[1,2-a]pyrazine]" [P]. US Patent, US 11053734 B2, 2015-03-06.
发明人林芳,杨光,刘建华. "A Process for Preparing High-Purity 3',4'-Dihydro-2'H-spiro[cyclohexane-1,1'-pyrrolo[1,2-a]pyrazine]" [P]. 中国发明专利, 专利号 CN 110535581 A, 授权公告日 2016-11-04.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2019, 1848, (4), 2741-2770.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2013, 1592, 7557-7584.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of 3',4'-Dihydro-2'H-spiro[cyclohexane-1,1'-pyrrolo[1,2-a]pyrazine] Using HRMS and NMR". J. Chromatogr. A, 2016, 651, (10), 2752-2778.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2016, 2274, 6932-6959.